Standalone Financial Results, Limited Review Report for June 30, 2016
Orchid Pharma Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Standalone Limited Review for the period ended June 30, 2016 Board Meeting Intimation for Results & Closure of Trading Window
Orchid Pharma Ltd has informed BSE that a meeting of the Board of Directors is proposed to be held on August 13, 2016, to approve the Unaudited financial results of the Company for the period from April 01, 2016 to June 30, 2016.As required under the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the securities of the Company shall remain closed for all the Insiders from August 02, 2016 to August 16, 2016 (both days inclusive). Statement on Impact of Audit Qualifications for the period ended March 31, 2016
Orchid Pharma Ltd has submitted to BSE a copy of Standalone Statement on Impact of Audit Qualifications for the period ended March 31, 2016 & Consolidated Statement on Impact of Audit Qualifications for the period ended March 31, 2016. Shareholding for the Period Ended June 30, 2016
Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Orchid Pharma Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Resignation of Non-executive & Non-independent Director
Orchid Pharma Ltd has informed BSE that the Company have received a letter dated May 31, 2016 from Shri S. Krishnan, non-executive & non-independent Director wherein he has resigned from the Board and Committees of Board of the Company with effect from May 31, 2016 and the Board has accepted his resignation. Results Press Release for March 31, 2016
Orchid Pharma Ltd has informed BSE about : 1. Result Press Release for the period ended March 31, 2016 Standalone & Consolidated Financial Results, Form B, Auditors Report for March 31, 2016
Orchid Pharma Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Consolidated Financial Results for the period ended March 31, 20163. Standalone Form B for the period ended March 31, 20164. Consolidated Form B for the period ended March 31, 20165. Standalone Auditors Report for the period ended March 31, 20166. Consolidated Auditors Report for the period ended March 31, 2016 Board Meeting Intimation for Results & Closure of Trading Window
Orchid Pharma Ltd has informed BSE that a meeting of the Board of Directors is proposed to be held on May 27, 2016, to approve the Audited financial results of the Company for the period from April 01, 2015 to March 31, 2016.As required under the SEBI (Prohibition of Insider Trading) Regulations, the trading window for dealing in the securities of the Company shall remain closed for all the Insiders from May 18, 2016 to May 30, 2016 (both days inclusive).